わかもと製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4512/E00928 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2017/03/24 | 日証協 | 33,312株 | -28.07% | 10,000株 | -79.17% | 86,033株 | -10.7% | 25,000株 | +56.25% |
| 2017/03/17 | 日証協 | 46,312株 | -11.47% | 48,000株 | -11.11% | 96,343株 | +1.05% | 16,000株 | -38.46% |
| 2017/03/10 | 日証協 | 52,312株 | +91.53% | 54,000株 | +12.5% | 95,343株 | +24.89% | 26,000株 | +224.63% |
| 2017/03/03 | 日証協 | 27,312株 | -55.45% | 48,000株 | +9.09% | 76,343株 | -19.92% | 8,009株 | -74.17% |
| 2017/02/24 | 日証協 | 61,312株 | +55.96% | 44,000株 | +340% | 95,333株 | +23.28% | 31,001株 | +287.51% |
| 2017/02/17 | 日証協 | 39,312株 | -26.26% | 10,000株 | -66.67% | 77,333株 | -28.62% | 8,000株 | -72.41% |
| 2017/02/10 | 日証協 | 53,312株 | +12.68% | 30,000株 | -50% | 108,333株 | +5.86% | 29,000株 | +141.67% |
| 2017/02/03 | 日証協 | 47,312株 | -15.98% | 60,000株 | +71.43% | 102,333株 | +4.07% | 12,000株 | -57.14% |
| 2017/01/27 | 日証協 | 56,312株 | -11.06% | 35,000株 | -2.78% | 98,333株 | -1.01% | 28,000株 | +460% |
| 2017/01/20 | 日証協 | 63,312株 | +3.26% | 36,000株 | +140% | 99,333株 | -9.15% | 5,000株 | -61.54% |
| 2017/01/13 | 日証協 | 61,312株 | -4.66% | 15,000株 | -60.53% | 109,333株 | +2.82% | 13,000株 | +62.5% |
| 2017/01/06 | 日証協 | 64,312株 | +4.89% | 38,000株 | -54.22% | 106,333株 | +26.09% | 8,000株 | -70.37% |
| 2016/12/30 | 日証協 | 61,312株 | +3.37% | 83,000株 | +69.39% | 84,334株 | -19.17% | 27,000株 | +285.71% |
| 2016/12/22 | 日証協 | 59,312株 | +1.71% | 49,000株 | -37.97% | 104,334株 | +9.44% | 7,000株 | -73.08% |
| 2016/12/16 | 日証協 | 58,312株 | +20.7% | 79,000株 | +102.56% | 95,333株 | +5.53% | 26,001株 | +52.95% |
| 2016/12/09 | 日証協 | 48,312株 | +49.52% | 39,000株 | +85.71% | 90,335株 | +8.4% | 17,000株 | -5.56% |
| 2016/12/02 | 日証協 | 32,312株 | -43.62% | 21,000株 | +320% | 83,335株 | -12.59% | 18,000株 | +38.46% |
| 2016/11/25 | 日証協 | 57,312株 | +7.5% | 5,000株 | -77.27% | 95,335株 | +1.06% | 13,000株 | +85.71% |
| 2016/11/18 | 日証協 | 53,312株 | +17.66% | 22,000株 | +15.79% | 94,335株 | +6.79% | 7,000株 | -65% |
※株式分割は考慮していませんのでご注意ください。
Page Top